Shareholding disclosure

Newron Pharmaceuticals SpA

Declared position

5.99%

Threshold

Crossed downwards

Timeline

Published

05.01.2017

Transaction

01.05.2014

Voting rights breakdown

Voting rights acquired0%

Voting rights sold5.99%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH1400029

Beneficial owner

Newron Pharmaceuticals SpA

Declared address

Newron Pharmaceuticals SpA, 20091 Bresso (MI)

Entering into force of revised disclosure laws, number of sales positions are up to date as of 12 October 2016

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Newron Pharmaceuticals SpA

Newron Pharmaceuticals S.p.A.05.01.2017TAH1400029

Disclosure summary

Newron Pharmaceuticals SpA disclosed a holding in Newron Pharmaceuticals S.p.A. on the disposal side, published by SIX Exchange Regulation on 05.01.2017, at 5.99% of voting rights. Notice category: Single shareholder.

Disclosed position

5.99%

Voting rights sold

Voting rights acquired0%

Voting rights sold5.99%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Newron Pharmaceuticals SpA disclosed a holding in Newron Pharmaceuticals S.p.A., published on 05.01.2017.

Publication date05.01.2017

Transaction date01.05.2014

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerNewron Pharmaceuticals SpA

Declared addressNewron Pharmaceuticals SpA, 20091 Bresso (MI)

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold5.99%

Below threshold0%

ExchangeXSWX

Notification IDTAH1400029

Conditions

Entering into force of revised disclosure laws, number of sales positions are up to date as of 12 October 2016

Source: SIX Exchange Regulation · Publication date: 05.01.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open